Latest News

The listing below shows our latest News Items and is updated regularly.  If you wish to post a news item please select the 'Post News' button on the right.  The displayed news feed starts on 1st August 2016.  Older items can be found here.

To 'Post Your News' use the button at the top right.



From the monthly archives: May, 2019

We are pleased to present below all posts archived in 'May, 2019'. If you still can't find what you are looking for, try using the search box.

ProBioGen and Vaccitech Sign License Agreement for ProBioGen’s Technology Platform

BERLIN, Germany, and OXFORD, United Kingdom, May 15, 2019 / B3C newswire / -- ProBioGen AG, a premier German service & technology provider for complex biologics and Vaccitech, Ltd., a spin-out company from the University of Oxford’s Jenner Institute, one of the most renowned vaccine research centers in the world, today jointly announced signing a license agreement.

Read the rest of entry »

Boyds bolsters Regulatory Affairs team with senior appointment

In support of its continuing growth plans, Boyds, the leading consultancy business that supports the development of pharmaceutical and biotech products for patient benefit, has appointed a new CMC regulatory affairs professional.

Read the rest of entry »

Boyds reports record-breaking growth 12-months on from Queen’s Award

Boyds, the leading consultancy business that supports the development of pharmaceutical and biotech products for patient benefit, has reported record-breaking growth in its overseas turnover in the 12-months since it was recognised with one of the UK’s most prestigious awards, The Queen’s Awards for Enterprise.

Read the rest of entry »

Catsci: Cardiff-based company expanding after Welsh Government support

A Cardiff-based company specialising in helping pharmaceutical companies bring new therapeutics to market is set to create 16 highly skilled new jobs thanks to Welsh Government support.

Read the rest of entry »

Immunocore to Present New Tebentafusp (IMCgp100) Data in Advanced Melanoma at Upcoming 2019 ASCO Annual Meeting

(Oxfordshire, UK and Conshohocken, Pennsylvania and Rockville, Maryland, US, 16 May 2019) Immunocore Limited, a leading T cell receptor (TCR) biotechnology company, will present new mechanism of action data in advanced uveal and cutaneous melanoma from the tebentafusp clinical research programme at the American Society of Clinical Oncology (ASCO) Annual Meeting in Chicago on 3 June 2019.

Read the rest of entry »

Leaf Expression Systems Ltd: Plant Bioscience Ltd transfers control of Hypertrans® plant-based biologics and vaccines expression technology to Leaf Expression Systems Ltd

14 May 2019: Norwich Plant Bioscience Ltd (PBL) and Leaf Expression Systems Ltd (Leaf) are delighted to announce a further development in their relationship, with PBL granting Leaf the exclusive rights to sub-license the Hypertrans® transient expression system, the core technology underpinning Leaf’s biologics and vaccines contract development and manufacturing services business.

Read the rest of entry »

World Courier: White Paper: Logistics by Design - a Framework for Advanced Therapy Developers

The Logistics by Design white paper uses a risk based framework that identifies areas within your supply chain that need to be addressed at the earliest possible moment.

Read the rest of entry »

RSSL introduces cell based bioassays to enhance biologics service offering

Reading Scientific Services Ltd (RSSL), a leading provider of scientific and technical solutions to the global biopharmaceutical, pharmaceutical and healthcare sectors, has introduced a cell based bioassay service to meet rising demand for potency assessments.

Read the rest of entry »

AMSBIO: Low Adhesion Plates Facilitate Retinal Organoid Culture

AMSBIO reports on how several leading European research groups have used their Lipidure® coated microplates to help culture physiologically functional, light-responsive retinal organoids.

 

Read the rest of entry »

Blue Earth Diagnostics continues to expand access to Axumin® (fluciclovine (18F)) in Europe

Oxford, UK – May 9, 2019 – Blue Earth Diagnostics, a leading molecular imaging diagnostics company, today announced expanded access to Axumin® (fluciclovine (18F)) in Europe. The first commercial production of Axumin in Belgium occurred recently, with the first Belgian patients being dosed.

Read the rest of entry »

Pages: Previous12NextReturn Top

Search Posts

News Policy

OBN aims to provide sector NEWS that is relevant to our Membership. We filter information from a variety of sources, publish items ourselves and will publish items of News from our Members. Press releases about OBN can be found here.